Skip to main content

Pharma News

academics

 

Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The drug fasudil is found to reverse key symptoms of schizophrenia in mice

    A team from Nagoya University in Japan used the drug fasudil to reverse two common symptoms associated with schizophrenia: reduced density of pyramidal neurons and cognitive dysfunction associated with methamphetamine treatment. Their findings, which were published in Pharmacological Research, suggest new therapeutic approaches for treating schizophrenia patients.

  • HPCI Exhibition & Conference 2023

    HPCI Exhibition & Conference 2023 was held on 16 and 17 February, 2023 at Jio World Convention Centre, BKC, Mumbai. It was organised by ExpoNova Exhibitions & Conferences (India) Pvt. Ltd. It was focused on raw materials and techniques for the formulation of cosmetic and cleaning products. It is indeed a place where industry meets, discovers new ingredient and technology, learns about various innovation.

  • NIH RECOVER research identifies potential long COVID disparities

    Black and Hispanic Americans appear to experience more symptoms and health problems related to long COVID(link is external), a lay term that captures an array of symptoms and health problems, than white people, but are not as likely to be diagnosed with the condition, according to new research funded by the National Institutes of Health.

  • Toxic protein linked to muscular dystrophy and arhinia

    Researchers at the National Institutes of Health and their colleagues have found that a toxic protein made by the body called DUX4 may be the cause of two very different rare genetic disorders. For patients who have facioscapulohumeral muscular dystrophy (FSHD), or a rare facial malformation called arhinia, this research discovery may eventually lead to therapies that can help people with these rare diseases.

  • Cipla ​has received 8 inspectional observations in Form 483

    Cipla has received 8 inspectional observations in Form 483 from USFDA after cGMP inspection at Pithampur plant.

    United States Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at Pithampur manufacturing facility of Cipla from 6th – 17th February, 2023.

    Cipla said that it will work closely with the USFDA and is committed to address these comprehensively within stipulated time.

  • Oral bacteria may increase heart disease risk

    Infection with a bacterium that causes gum disease and bad breath may increase the risk of heart disease, shows a study published today in eLife.

    The study suggests another potential risk factor that physicians might screen for to identify individuals at risk of heart disease. It may also indicate that treatments for colonisation or infection with the oral bacterium Fusobacterium nucleatum may help reduce heart disease risk.

  • Rice scientists reengineer cancer drugs to be more versatile

    Rice University scientists have enlisted widely used cancer therapy systems to control gene expression in mammalian cells, a feat of synthetic biology that could change how diseases are treated. lab shotRice University scientists have enlisted widely used cancer therapy systems to control gene expression in mammalian cells, a feat of synthetic biology that could change how diseases are treated.

  • Countries unite to remove mercury from hazardous skin lightening products

    The governments of Gabon, Jamaica and Sri Lanka have joined forces to fight back against damaging beauty practices, launching a joint 14-million USD project to eliminate the use of mercury in skin lightening products.

    Using cosmetics to inhibit the body’s production of melanin, leading the skin to appear lighter, is a centuries-old practice in many parts of the world that continues to take a toxic toll today.

  • Flipkart, Amazon served notices for selling online medicines without license

    Flipkart, Amazon and other online pharmacies are served notices by DCGI for selling online medicines without license. DCGI mentioned that online sales of medicine without proper license is illegal as per the order by Honorable High Court of Delhi.

  • Pfizer announces the appointment of Meenakshi Nevatia as the Managing Director and Additional Director

    Pfizer Limited announced that its Board of Directors has appointed Meenakshi Nevatia as an Additional Director and the Managing Director for a period of five years with effect from 3rd April 2023. She succeeds S.Sridhar, who announced his early retirement in August 2022.

Subscribe to Pharma News